PLTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy now (tactical entry). PLTR is deeply oversold (RSI_6 14) and trading right on key support (151.7) after a pullback, which creates a favorable near-term rebound setup. Fundamentals remain strong (Q3 2025 hyper-growth + margin strength), analyst targets are broadly rising with fresh Buy initiations, and an earnings catalyst is imminent (Feb 2 after hours). Even though momentum indicators are still bearish (negative/expanding MACD), the current price level offers an attractive “buy-the-dip” entry for an impatient investor who doesn’t want to wait for a perfect setup.
Price/Trend: PLTR at ~150 is below the pivot (165.18) and slightly under S1 (151.69), implying the short-term trend is down and the stock is testing support. Momentum: MACD histogram -2.092 and negatively expanding = bearish momentum still in control, so downside follow-through is possible. Mean-reversion: RSI_6 ~13.97 is extremely oversold, which often precedes a reflex bounce, especially near support. Levels: Immediate support S1 ~151.69 (already being tested) then S2 ~143.35; resistance levels are pivot 165.18 then R1 178.66. Pattern-based odds (provided): 70% chance of -0.96% next day, +0.99% next week, +10.96% next month—near-term choppy but biased higher over a month.
Intellectia Proprietary Trading Signals Intellectia Proprietary Trading Signals
Earnings catalyst: QDEC 2025 earnings on 2026-02-02 after hours (Est EPS ~0.23). With the stock oversold, a solid print/guide can trigger a sharp rebound.
Strong fundamental trajectory (latest quarter): 2025/Q3 revenue +62.79% YoY, net income +231.37% YoY, EPS +200% YoY, and gross margin ~82.45% (up YoY).
Wall Street targets have moved higher into late 2025/early 2026 with fresh Buy initiations (Phillip Securities $208, Truist $223), reinforcing an upside narrative.
News tie-in: Partnership-related headlines (e.g., Innodata + Palantir AI data services) support ongoing commercialization of AI deployments.
Technical momentum is still bearish: MACD histogram is negative and expanding, so the selloff can continue before any durable bottom forms; next support sits near ~143.
Options flow is modestly defensive: put volume slightly exceeds call volume (volume put/call 1.07), suggesting near-term caution/hedging.
Valuation concerns persist in the analyst community (e.g., at least one Sell/Underperform stance highlights premium valuation and uncertainty about normalized growth after early AIP rollouts).
Macro/news backdrop: mixed tech earnings environment and sector cross-currents could cap short-term multiple expansion.
Latest quarter (2025/Q3): Revenue rose to ~$1.181B (+62.79% YoY), net income to ~$475.6M (+231.37% YoY), EPS to $0.18 (+200% YoY), and gross margin expanded to ~82.45% (+3.33% YoY). This shows accelerating top-line growth alongside improving profitability and strong margin structure—supportive of buying dips despite near-term technical weakness.
Recent trend: Price targets have broadly been revised upward since the strong Q3 results (multiple raises and reiterations), and early 2026 saw two notable Buy initiations with high targets (Phillip $208; Truist $223). However, several major banks remain Neutral/Hold/Equal Weight even while lifting targets (Goldman $188 Neutral, UBS $205 Neutral, Morgan Stanley $205 Equal Weight, HSBC $197 Hold, DA Davidson $215 Neutral), reflecting a “great business, pricey stock” split. Bear case still exists: RBC kept Underperform (PT $50) and Freedom Capital kept Sell (PT $170) citing valuation and sustainability/visibility concerns. Overall Wall Street view: constructive on AI-driven growth and margins, but divided on how much of that is already priced in. Trading activity check: Hedge funds and insiders are neutral (no significant recent trend). Politician/congress activity: No recent congress trading data available.
